Analysis Biome Technologies PLC (BIOM)
5/29/2024
Analysis of Biome Technologies PLC (BIOM)
Biome Technologies PLC has shown some volatility in its stock price recently. The Relative Strength Index (RSI) indicates a neutral sentiment around 55.42, suggesting that the stock is neither overbought nor oversold.The Moving Average Convergence Divergence (MACD) indicator is negative, with the MACD line below the signal line. However, the MACD histogram is showing signs of convergence, which could indicate a potential trend reversal.
The stock has been trading above its Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) in the recent days, which could be a positive sign for the short-term trend.
Overall, the stock seems to be consolidating after a period of volatility, and investors may want to monitor the MACD histogram for potential trend changes in the coming days.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The quarter before that, ending on January 31, 2025, had results released after hours. The results for the quarter ending on October 31, 2024, were not provided at the time. However, for the quarter ending on August 1, 2024, the company had an EPS estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits for a particular company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio and a high total debt to equity ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown a positive return on assets and return on equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and forward PE ratio, with the company's market capitalization and enterprise value being substantial. The price to book ratio and price to sales ratio are also on the higher side.
The stock price summary includes beta, moving averages, and the range of prices over the past year.
Lastly, dividends and splits data show the company's dividend history, payout ratio, and dividend yield metrics. The company has a regular dividend payout and has undergone a stock split in the past.
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales have been increasing steadily over the past four years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. The gross profit margin has been relatively stable, ranging from 38% to 44% over the same period.
3. Operating income has also shown a consistent growth trend, reaching $114.3 billion in 2023 from $66.3 billion in 2020.
4. Net income has been increasing year over year, with a significant jump from $57.4 billion in 2020 to $97 billion in 2023.
5. Earnings per share (EPS) have shown a positive trend, with both basic and diluted EPS increasing over the years.
6. The company has been able to maintain a healthy EBITDA margin, hovering around 33-35%.
7. Despite an increase in income tax expenses, the company has managed to grow its net income consistently.
8. The company has been able to control its operating expenses effectively, allowing for the growth in operating income and net income.
9. Overall, the financial performance of the company in terms of revenues has been strong and shows a positive growth trajectory.
Balance Sheet
These are balance sheets. Here are the conclusions based on the data provided:1. The total assets of the company have been increasing over the years, reaching the highest value of $365,725,000,000 in 2018.
2. Current assets include cash, inventory, and accounts receivable, with cash and cash equivalents showing fluctuations over the years.
3. Non-current assets consist of investments, machinery, furniture, and equipment, which have been increasing steadily.
4. Total liabilities have also been increasing, with the highest value recorded in 2018 at $255,355,000,000.
5. Current liabilities include short-term debt, accounts payable, and deferred revenue, showing variations annually.
6. Non-current liabilities comprise long-term debt and other non-current liabilities, which have shown an increasing trend.
7. Shareholders' equity has been fluctuating but generally increasing, with the highest value recorded in 2018 at $107,147,000,000.
Overall, the company has been growing its assets and liabilities over the years, with fluctuations in different financial components.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its highest value in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.33, which is higher than the EPS of $1.26 from the same quarter a year ago. The range of estimates is between $1.27 and $1.36, as provided by 26 analysts.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is $1.53, compared to $1.46 from the previous year. The estimates range from $1.44 to $1.63, based on 25 analysts.
3. Looking at the current fiscal year ending on September 30, 2024, the average estimated EPS is $6.59, an increase from the previous year's EPS of $6.13. The analysts' estimates range from $6.43 to $6.92, with insights from 39 analysts.
4. Moving on to the next fiscal year ending on September 30, 2025, the average estimated EPS is $7.23, with a range of estimates between $6.40 and $7.90. This is compared to the EPS of $6.59 from the previous fiscal year, based on projections from 39 analysts.
Overall, the analysts are forecasting an increase in earnings per share for both the upcoming quarters and fiscal years, indicating positive growth expectations for the company.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year.
Growth estimates
Based on the consensus estimates provided, we can draw the following conclusions regarding the growth rate of the company for different periods:1. Current Quarter: The estimated growth rate for the current quarter is 5.6%.
2. Next Quarter: The estimated growth rate for the next quarter is 4.8%.
3. Current Year: The estimated growth rate for the current year is 7.5%.
4. Next Year: The estimated growth rate for the next year is 9.7%.
5. Past 5 Years (per annum): The average annual growth rate for the past 5 years is 20.1%.
6. Next 5 Years (per annum): The estimated average annual growth rate for the next 5 years is 11%.
These estimates suggest a positive growth trend for the company, with a slightly lower growth rate expected in the next 5 years compared to the past 5 years. The company is projected to experience steady growth in the short term, with a higher growth rate expected in the next year compared to the current year.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the current price of $191.57 is below both the average and median forecasted prices. The analysts' predictions suggest a potential increase in the price of the security, with a high estimate of $250. Investors may consider these forecasts when making decisions about buying or selling the security.
MACD of BIOM
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
